Development and Pharmacokinetic Evaluation of Two Parenteral Formulations of Albendazole Using Prodrug and Cosolvent Approaches
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Development and Pharmacokinetic Evaluation of Two Parenteral Formulations of Albendazole Using Prodrug and Cosolvent Approaches ; volume:24 ; number:6 ; day:27 ; month:7 ; year:2023 ; pages:1-10 ; date:8.2023
AAPS PharmSciTech / American Association of Pharmaceutical Scientists ; 24, Heft 6 (27.7.2023), 1-10, 8.2023
- Creator
-
Becerril-Vega, José
Hernández-Campos, Alicia
González-Hernández, Iliana
Flores-Ramos, Miguel
Castillo, Rafael
Leyva-Gómez, Gerardo
Mayet-Cruz, Lourdes
Jung-Cook, Helgi
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1208/s12249-023-02613-9
- URN
-
urn:nbn:de:101:1-2023110608453579090247
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Becerril-Vega, José
- Hernández-Campos, Alicia
- González-Hernández, Iliana
- Flores-Ramos, Miguel
- Castillo, Rafael
- Leyva-Gómez, Gerardo
- Mayet-Cruz, Lourdes
- Jung-Cook, Helgi
- SpringerLink (Online service)
Other Objects (12)
Standardised neonatal parenteral nutrition formulations – Australasian neonatal parenteral nutrition consensus update 2017
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Standardised neonatal parenteral nutrition formulations – an Australasian group consensus 2012
Pharmacokinetic and Safety Study of Bismuth Potassium Citrate Formulations in Healthy Subjects
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential
Lyso-phosphatidylcholine as an interfacial stabilizer for parenteral monoclonal antibody formulations
Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers
Pharmacokinetic Bioequivalence of Two Inhaled Tiotropium Bromide Formulations in Healthy Volunteers
Fatty acid-modified poly(glycerol adipate) as a versatile matrix for parenteral depot formulations
Novel glycosyl prodrug of RXP03 as MMP-11 prodrug: design, synthesis and virtual screening
Standardised neonatal parenteral nutrition formulations – Australasian neonatal parenteral nutrition consensus update 2017
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Standardised neonatal parenteral nutrition formulations – an Australasian group consensus 2012
Pharmacokinetic and Safety Study of Bismuth Potassium Citrate Formulations in Healthy Subjects
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential
Lyso-phosphatidylcholine as an interfacial stabilizer for parenteral monoclonal antibody formulations
Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers
Pharmacokinetic Bioequivalence of Two Inhaled Tiotropium Bromide Formulations in Healthy Volunteers
Fatty acid-modified poly(glycerol adipate) as a versatile matrix for parenteral depot formulations
Novel glycosyl prodrug of RXP03 as MMP-11 prodrug: design, synthesis and virtual screening
Standardised neonatal parenteral nutrition formulations – Australasian neonatal parenteral nutrition consensus update 2017
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Standardised neonatal parenteral nutrition formulations – an Australasian group consensus 2012
Pharmacokinetic and Safety Study of Bismuth Potassium Citrate Formulations in Healthy Subjects
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential
Lyso-phosphatidylcholine as an interfacial stabilizer for parenteral monoclonal antibody formulations
Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers
Pharmacokinetic Bioequivalence of Two Inhaled Tiotropium Bromide Formulations in Healthy Volunteers
Fatty acid-modified poly(glycerol adipate) as a versatile matrix for parenteral depot formulations